These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

349 related articles for article (PubMed ID: 31362139)

  • 1. Implantable microneedles with an immune-boosting function for effective intradermal influenza vaccination.
    Chen YH; Lai KY; Chiu YH; Wu YW; Shiau AL; Chen MC
    Acta Biomater; 2019 Oct; 97():230-238. PubMed ID: 31362139
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enhancing immunogenicity of antigens through sustained intradermal delivery using chitosan microneedles with a patch-dissolvable design.
    Chen MC; Lai KY; Ling MH; Lin CW
    Acta Biomater; 2018 Jan; 65():66-75. PubMed ID: 29109028
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Microneedle vaccination with stabilized recombinant influenza virus hemagglutinin induces improved protective immunity.
    Weldon WC; Martin MP; Zarnitsyn V; Wang B; Koutsonanos D; Skountzou I; Prausnitz MR; Compans RW
    Clin Vaccine Immunol; 2011 Apr; 18(4):647-54. PubMed ID: 21288996
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cross-protection by co-immunization with influenza hemagglutinin DNA and inactivated virus vaccine using coated microneedles.
    Kim YC; Yoo DG; Compans RW; Kang SM; Prausnitz MR
    J Control Release; 2013 Dec; 172(2):579-88. PubMed ID: 23643528
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intradermal vaccination with influenza virus-like particles by using microneedles induces protection superior to that with intramuscular immunization.
    Quan FS; Kim YC; Vunnava A; Yoo DG; Song JM; Prausnitz MR; Compans RW; Kang SM
    J Virol; 2010 Aug; 84(15):7760-9. PubMed ID: 20484519
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fully embeddable chitosan microneedles as a sustained release depot for intradermal vaccination.
    Chen MC; Huang SF; Lai KY; Ling MH
    Biomaterials; 2013 Apr; 34(12):3077-86. PubMed ID: 23369214
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Insertion-responsive microneedles for rapid intradermal delivery of canine influenza vaccine.
    Choi IJ; Kang A; Ahn MH; Jun H; Baek SK; Park JH; Na W; Choi SO
    J Control Release; 2018 Sep; 286():460-466. PubMed ID: 30102940
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhanced memory responses to seasonal H1N1 influenza vaccination of the skin with the use of vaccine-coated microneedles.
    Kim YC; Quan FS; Yoo DG; Compans RW; Kang SM; Prausnitz MR
    J Infect Dis; 2010 Jan; 201(2):190-8. PubMed ID: 20017632
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sodium Hyaluronate/Chitosan Composite Microneedles as a Single-Dose Intradermal Immunization System.
    Chiu YH; Chen MC; Wan SW
    Biomacromolecules; 2018 Jun; 19(6):2278-2285. PubMed ID: 29722966
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stable incorporation of GM-CSF into dissolvable microneedle patch improves skin vaccination against influenza.
    Littauer EQ; Mills LK; Brock N; Esser ES; Romanyuk A; Pulit-Penaloza JA; Vassilieva EV; Beaver JT; Antao O; Krammer F; Compans RW; Prausnitz MR; Skountzou I
    J Control Release; 2018 Apr; 276():1-16. PubMed ID: 29496540
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Microneedle Vaccination Elicits Superior Protection and Antibody Response over Intranasal Vaccination against Swine-Origin Influenza A (H1N1) in Mice.
    Shin JH; Park JK; Lee DH; Quan FS; Song CS; Kim YC
    PLoS One; 2015; 10(6):e0130684. PubMed ID: 26086590
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Increasing the immunogenicity of inactivated chitosan adjuvanted vaccine from A/California/7/09 (H1N1) strain and analyzing the antigenic specificity of this influenza virus strain].
    Gendon IuZ; Markushin SG; Vasil'ev IuM; Akopova II; Krivtsov GG
    Vopr Virusol; 2012; 57(1):28-33. PubMed ID: 22624470
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term protective immunity from an influenza virus-like particle vaccine administered with a microneedle patch.
    Quan FS; Kim YC; Song JM; Hwang HS; Compans RW; Prausnitz MR; Kang SM
    Clin Vaccine Immunol; 2013 Sep; 20(9):1433-9. PubMed ID: 23863506
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dose sparing enabled by skin immunization with influenza virus-like particle vaccine using microneedles.
    Quan FS; Kim YC; Compans RW; Prausnitz MR; Kang SM
    J Control Release; 2010 Nov; 147(3):326-32. PubMed ID: 20692307
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A boosting skin vaccination with dissolving microneedle patch encapsulating M2e vaccine broadens the protective efficacy of conventional influenza vaccines.
    Zhu W; Pewin W; Wang C; Luo Y; Gonzalez GX; Mohan T; Prausnitz MR; Wang BZ
    J Control Release; 2017 Sep; 261():1-9. PubMed ID: 28642154
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preparation of H1N1 microneedles by a low-temperature process without a stabilizer.
    Jeong HR; Park S; Park JH; Bae JY; Kim GY; Baek SK; Park MS; Park JH
    Eur J Pharm Biopharm; 2019 Oct; 143():1-7. PubMed ID: 31398438
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dissolving polymer microneedle patches for influenza vaccination.
    Sullivan SP; Koutsonanos DG; Del Pilar Martin M; Lee JW; Zarnitsyn V; Choi SO; Murthy N; Compans RW; Skountzou I; Prausnitz MR
    Nat Med; 2010 Aug; 16(8):915-20. PubMed ID: 20639891
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Microneedle patch delivery of influenza vaccine during pregnancy enhances maternal immune responses promoting survival and long-lasting passive immunity to offspring.
    Esser ES; Pulit-Penaloza JA; Kalluri H; McAllister D; Vassilieva EV; Littauer EQ; Lelutiu N; Prausnitz MR; Compans RW; Skountzou I
    Sci Rep; 2017 Jul; 7(1):5705. PubMed ID: 28720851
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bacterium-like particles supplemented with inactivated influenza antigen induce cross-protective influenza-specific antibody responses through intranasal administration.
    de Haan A; Haijema BJ; Voorn P; Meijerhof T; van Roosmalen ML; Leenhouts K
    Vaccine; 2012 Jul; 30(32):4884-91. PubMed ID: 22537989
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Formulation and coating of microneedles with inactivated influenza virus to improve vaccine stability and immunogenicity.
    Kim YC; Quan FS; Compans RW; Kang SM; Prausnitz MR
    J Control Release; 2010 Mar; 142(2):187-95. PubMed ID: 19840825
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.